menu
    • menu

    Company profile for Kite Pharma

    NEW Drugs in Dev: 17
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development.For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potent...
    Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development.For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kite PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    333 Lakeside Drive Foster City, CA 94404
    Telephone
    Telephone
    650-574-3000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kitepharma.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/kite-pharma-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/KitePharma?protected_redirect=true

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cencora to Handle U.S. Distribution for Kite's CAR T Therapies
    Cencora to Handle U.S. Distribution for Kite's CAR T Therapies

    02 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260602642163/en/Cencora-to-Support-U.S.-Distribution-of-Kites-CAR-T-Cell-Therapies

    BUSINESSWIRE
    02 Jun 2026
    Share Share
    Gilead & Kite Show ADC and Cell Therapy Data at ASCO, EHA 2026
    Gilead & Kite Show ADC and Cell Therapy Data at ASCO, EHA 2026

    21 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260520344508/en/New-ASCO-and-EHA-2026-Data-Demonstrate-Gilead-and-Kites-Momentum-Across-Antibody-Drug-Conjugates-and-Cell-Therapy-in-Oncology

    BUSINESSWIRE
    21 May 2026
    Share Share
    EMA Approves Safety Updates for Kite's Yescarta, Tecartus
    EMA Approves Safety Updates for Kite's Yescarta, Tecartus

    24 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7207834

    FIRSTWORD PHARMA
    24 Apr 2026
    Share Share
    The Next Cambridge? LA Sets Its Sights Higher
    The Next Cambridge? LA Sets Its Sights Higher

    12 Mar 2026

    // BIOSPACE

    https://www.biospace.com/job-trends/the-next-cambridge-la-sets-its-sights-higher

    BIOSPACE
    12 Mar 2026
    Share Share
    Yescarta® Shows Consistent Benefits in R/R LBCL at ASH 2025
    Yescarta® Shows Consistent Benefits in R/R LBCL at ASH 2025

    07 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251207097497/en/Yescarta-Delivers-Consistent-Safety-Efficacy-and-Quality-of-Life-Benefits-Across-Broad-Range-of-RelapsedRefractory-Large-B-cell-Lymphoma-Patients-in-New-Analysis-at-ASH-2025

    BUSINESSWIRE
    07 Dec 2025
    Share Share
    Kite Next-Gen Bicistronic CAR-T Shows Ph1 Promise in Lymphoma
    Kite Next-Gen Bicistronic CAR-T Shows Ph1 Promise in Lymphoma

    06 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251206612260/en/Kites-Next-Generation-Bicistronic-CAR-T-Cell-Therapies-Show-Encouraging-Phase-1-Results-in-RelapsedRefractory-B-Cell-Lymphoma-in-New-Data-at-ASH-2025

    BUSINESSWIRE
    06 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search